The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma (Q39607971)

13 September 2017

The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma (English)

1 reference

13 September 2017

Wenjuan Cai

1

1 reference

13 September 2017

Yan Sun

2

1 reference

13 September 2017

Wei Wang

3

1 reference

13 September 2017

Chunrong Han

4

1 reference

13 September 2017

Mamoru Ouchida

5

1 reference

13 September 2017

Wenbin Xia

6

1 reference

13 September 2017

Xiulan Zhao

7

1 reference

13 September 2017

Baocun Sun

8

1 reference

13 September 2017

language of work or name

1 reference

14 January 2011

1 reference

Pathology Oncology Research

13 September 2017

1 reference

13 September 2017

17

1 reference

13 September 2017

2

1 reference

13 September 2017

357-367

1 reference

https://scigraph.springernature.com/pub.10.1007/s12253-010-9334-y

13 September 2017

0 references

cites work

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Molecular mechanisms underlying human synovial sarcoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Fusions of the SYT and SSX genes in synovial sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Specific protection against breast cancers by cyclin D1 ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

The Akt pathway in human breast cancer: a tissue-array-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

Loss of p27 expression through RAS-->BRAF-->MAP kinase-dependent pathway in human thyroid carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9334-Y

SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.

21 January 2018

1 reference

12 December 2020

Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma

1 reference

12 December 2020

Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.

1 reference

12 December 2020

Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS)

1 reference

12 December 2020

The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.

1 reference

12 December 2020

Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity

1 reference

12 December 2020

Sodium phenylacetate inhibits the Ras/MAPK signaling pathway to induce reduction of the c-Raf-1 protein in human and canine breast cancer cells

1 reference

12 December 2020

Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas

1 reference

12 December 2020

The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery

1 reference

12 December 2020

10.1007/S12253-010-9334-Y

Identifiers

DOI

1 reference

13 September 2017

1 reference